A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of N6022 in Healthy Subjects.

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of N6022 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs N 6022 (Primary)
  • Indications Acute asthma; Asthma; Chronic obstructive pulmonary disease; Inflammatory bowel diseases
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 01 Aug 2011 Actual end date (August 2011) added as reported by ClinicalTrials.gov.
    • 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top